|
|
|
| A study on the integrated application of risk matrix and analytic hierarchy process in risk assessment of vaccination operation |
| HE Ben, XIANG Ze-lin, CHEN Zhong-wen, SHEN Guo-chu, DU Zhe-qun, ZHU Hong-liang
|
| The Center for Disease Control and Prevention of Jiaxing City, Jiaxing, Zhejiang, 314050, China |
|
|
|
|
Abstract Objective To evaluate the risks of vaccination operation in order to provide scientific basis for policy makings of vaccination operation.Methods The risk matrix and analytic hierarchy process approach were used to evaluate the risks of vaccination operation, including the possibility, severity, risk weight, and risk level.Results Seven items for the first level and thirty one items for the second level vaccination risk factors were determined. In the first level, E level risk (Extremely serious risk) was vaccination implementation risk, and H level risk (high risk) was the risks of pre-notification and health education and risks of vaccine and cold chain management. Vaccination implementation risk accounted the largest weight (weight coefficient=38.95%). In second level, E level risk was three inspection and seven verification before vaccination, and H level risk were personnel professional quality, personnel responsibility, pre-inspection, informed before vaccination, vaccination route, site and dose, vaccination operation, post vaccination notification and retention, and three inspection and seven verification before vaccination, accounted the largest weight(weight coefficient=10.14%). The weight of the logical consistency of the test results were satisfactory (consistency ratio<0.1).Conclusion The integrated application of risk matrix and analytic hierarchy process in risk assessment of vaccination operation helps to further regulate vaccination services and has application and promotion value.
|
|
Published: 26 December 2017
|
|
|
|
|
|
[1]石平.儿童预防接种的风险防范[J].中华临床医学研究杂志,2008,14(8):1217.
[2]裘炯良,郑剑宁,浦昀,等. 国境口岸传染病流行风险评估体系的建立及应用研究[J]. 中国国境卫生检疫杂志,2013,36(5): 338-343.
[3]尚晓鹏,王心怡,何凡,等. 浙江省埃博拉出血热输入及本地传播风险评估[J].浙江预防医学,2014,26(12):1206-1209.
[4]张镭,毕宏焱,解丽娜,等.综合应用Delphi法、风险矩阵法与Borda序值法评估医院病区药品管理风险[J].临床药物治疗杂志,2015,13(2):29-33.
[5]邓瑛,高婷,庞星火,等. 2008年北京奥运会公共卫生风险与保障对策的研究[J].中华预防医学杂志,2008,42(1): 4-7.
[6]石国祥,鞠成,张蓉. 浙江省五个鼠疫重点监测县(市)鼠疫风险评估及防控对策研究[J]. 中华预防医学杂志,2015,49(10): 896-900.
[7]金辉,宋金波,曲毅,等.我国药品风险管理现状的认识和思考[J].中国药物警戒,2010,7(4): 229-231.
[8]王辉,吴爵.应用德尔菲法探讨手术室护理风险评价方法的研究[J].全科护理, 2013, 11(2): 289-290.
[9]施能进,王刚. 药品质量风险管理在医院药房的实践[J].中国医院药学杂志, 2013, 33(12): 1000-1002.
[10]董肇君.系统工程与运筹学[M]. 北京:国防工业出版社,2007:57-60.
[11]Standards Australia/Standards New Zealand.AS/NZS 4360:2004: Australian/New Zealand Standard for Risk Management[S]. Standards Australia Standards New Zealand, 2010.
[12]刁连东,孙晓冬.实用疫苗学[M].上海:上海科学技术出版社, 2015.
[13]陈直平,陈恩富.免疫规划与预防接种[M].浙江:浙江文艺出版社,2009.
[14]陈恩富.社区预防接种使用手册[M].浙江:浙江科学技术出版社,2010.
[15]孙振球.医学统计学[M].北京:人民卫生出版社,2002:497-500.
[16]赵东丽, 赵夏钗, 吴月华. 预防接种风险因素分析及防范措施[J].中国保健营养,2014,24(2):839-840.
[17]陈苏兰. 预防接种风险因素与管理[J].浙江临床医学,2011,13(5): 599-600.
[18]闫海英. 加强预防接种工作风险防范管理的实践与探讨[J].中华临床医学杂志,2008,9(12):100-101.
[19]戚宏云,张惠思.免疫规划综合评价方法概述[J].甘肃医药,2014,33(10):743-745.
[20]余飞,陈洁,费苛,等.医院品牌效应的评估指标体系建立及应用[J].中华医院管理杂志,2011,27(2):132-134.
[21]于湘熹.基层免疫规划工作质量综合评价指标与方法探讨[J].中国初级卫生保健,2013,27(2):58-59.
[22]中华人民共和国国家质量监督检验检疫局,中国国家标准化管理委员会.风险管理-风险评估技术:GB/T 27921—2011[S].北京:中国标准出版社,2012. |
|
|
|
